STAASTAAR Surgical Company

STAA Stock Price, Valuation & Chart | STAAR Surgical Company

Compare

$23.110-0.41 (-1.74%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Instruments & Supplies STAA intrinsic value STAA calculated fair value vs price

Overview Financials Dividends Ratios

STAA Historical price chart

STAA Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization1.15B

PE Ratio40.54

EPS0.57

Trading Volume472.78K

Today's High/Low23.84/23.04

Dividend Yield0.00

52 Week High/Low35.87/15.59

Shares Outstanding49.79M

STAA Financial Statement

STAA Analyst ratings

STAA Analysis & performance metrics

STAA Company profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to…

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL,…

STAA Management team

Name

Position

Magda Michna Ph.D.

Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer

Nancy Sabin

Chief Marketing Officer

Warren FoustCOO

President & Chief Operating Officer

Nathaniel B. Sisitsky Esq.

Senior Vice President, Chief Legal Officer, General Counsel & Corporate Secretary

James Francese

Senior Vice President of Commercial Operations - North America & APAC

Brian Moore

Vice President of Investor Relations & Corporate Development

Thomas G. Frinzi

Advisor

Deborah J. AndrewsCFO

Interim Chief Financial Officer

Name

Position

Magda Michna Ph.D.

Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer

Nancy Sabin

Chief Marketing Officer

Warren FoustCOO

President & Chief Operating Officer

Nathaniel B. Sisitsky Esq.

Senior Vice President, Chief Legal Officer, General Counsel & Corporate Secretary

James Francese

Senior Vice President of Commercial Operations - North America & APAC

Brian Moore

Vice President of Investor Relations & Corporate Development

Thomas G. Frinzi

Advisor

Deborah J. AndrewsCFO

Interim Chief Financial Officer

Management Team

Magda Michna Ph.D.

Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer

Nancy Sabin

Chief Marketing Officer

Warren FoustCOO

President & Chief Operating Officer

Nathaniel B. Sisitsky Esq.

Senior Vice President, Chief Legal Officer, General Counsel & Corporate Secretary

James Francese

Senior Vice President of Commercial Operations - North America & APAC

Brian Moore

Vice President of Investor Relations & Corporate Development

Thomas G. Frinzi

Advisor

Deborah J. AndrewsCFO

Interim Chief Financial Officer

Management

Magda Michna Ph.D.

Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer

Nancy Sabin

Chief Marketing Officer

Warren FoustCOO

President & Chief Operating Officer

Nathaniel B. Sisitsky Esq.

Senior Vice President, Chief Legal Officer, General Counsel & Corporate Secretary

James Francese

Senior Vice President of Commercial Operations - North America & APAC

Brian Moore

Vice President of Investor Relations & Corporate Development

Thomas G. Frinzi

Advisor

Deborah J. AndrewsCFO

Interim Chief Financial Officer

Total 8 executives

STAA Frequently asked questions

What is STAAR Surgical Company (STAA) Stock Price?

Current stock price of STAAR Surgical Company (STAA) stock is $23.110. The stock price is -1.74% lower in the session. The intraday range can be seen from this page. Volume of STAAR Surgical Company (STAA) stock is 472.78K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the STAAR Surgical Company (STAA) stock price going up or down today?

The stock price of STAAR Surgical Company (STAA) can change with earnings, company news, and overall market sentiment. STAAR Surgical Company operates in the Healthcare / Medical - Instruments & Supplies market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the STAAR Surgical Company stock expensive at its current price?

Whether STAAR Surgical Company looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for STAA on this page is 40.54. EPS on this page is 0.57. Compare those figures with peers and growth expectations before deciding if the current STAAR Surgical Company price is justified.

How has the stock price of STAAR Surgical Company (STAA) performed historically?

Historical performance for STAAR Surgical Company (STAA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how STAA reacted to past earnings and market events.

Should I buy STAAR Surgical Company (STAA) stock, at this price?

Buying STAAR Surgical Company (STAA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.